HLS.AX
Healius Ltd
Price:  
1.08 
AUD
Volume:  
2,611,929.00
Australia | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HLS.AX EV/EBITDA

32.9%
Upside

As of 2025-05-18, the EV/EBITDA ratio of Healius Ltd (HLS.AX) is 7.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HLS.AX's latest enterprise value is 2,067.62 mil AUD. HLS.AX's TTM EBITDA according to its financial statements is 289.80 mil AUD. Dividing these 2 quantities gives us the above HLS.AX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 5.9x - 8.5x 7.3x
Forward P/E multiples 7.8x - 10.4x 8.8x
Fair Price 0.60 - 2.38 1.44
Upside -44.1% - 119.9% 32.9%
1.08 AUD
Stock Price
1.44 AUD
Fair Price

HLS.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-09 7.34
2025-05-08 8.30
2025-05-07 8.44
2025-05-06 8.40
2025-05-05 8.36
2025-05-02 8.20
2025-05-01 8.22
2025-04-30 8.07
2025-04-29 8.05
2025-04-28 7.92
2025-04-24 7.94
2025-04-23 7.86
2025-04-22 7.79
2025-04-17 7.86
2025-04-16 7.81
2025-04-15 7.84
2025-04-14 7.89
2025-04-11 7.92
2025-04-10 8.07
2025-04-09 7.92
2025-04-08 7.77
2025-04-07 7.72
2025-04-04 7.89
2025-04-03 7.96
2025-04-02 7.90
2025-04-01 7.82
2025-03-31 7.95
2025-03-28 8.05
2025-03-27 8.07
2025-03-26 7.71
2025-03-25 7.79
2025-03-24 7.79
2025-03-21 7.77
2025-03-20 7.76
2025-03-19 7.71
2025-03-18 7.74
2025-03-17 7.70
2025-03-14 7.74
2025-03-13 7.68
2025-03-12 7.64
2025-03-11 7.75
2025-03-10 7.87
2025-03-07 7.97
2025-03-06 8.05
2025-03-05 7.94
2025-03-04 7.82
2025-03-03 7.74
2025-02-28 7.67
2025-02-27 7.79
2025-02-26 7.79